We have just started a cash flow positive run.
This quarterly (q3) should be supplemented with the R&D refund and therefor a positive cash flow. Next quarterly (q4) these new releases should be sufficient to tip it into positive territory. The following quarters will see new releases and continued growth of these products.
i believe we are on the tipping point people!
Add to My Watchlist
What is My Watchlist?